Beijing Tong Ren Tang Chinese Medicine Co (HK:3613) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Beijing Tong Ren Tang Chinese Medicine Company Limited announced that all proposed resolutions were passed at their Annual General Meeting on June 7, 2024, with overwhelming shareholder support, including the reelection of executive directors and the approval of a final dividend of HK$0.33 per share for the year ended December 31, 2023. Additionally, a general mandate for share issuance and repurchase was approved, along with an extension contingent on these mandates.
For further insights into HK:3613 stock, check out TipRanks’ Stock Analysis page.